TY - JOUR
T1 - BRCA2-HSF2BP oligomeric ring disassembly by BRME1 promotes homologous recombination
AU - Ghouil, Rania
AU - Miron, Simona
AU - Sato, Koichi
AU - Ristic, Dejan
AU - van Rossum-Fikkert, Sari E.
AU - Legrand, Pierre
AU - Ouldali, Malika
AU - Winter, Jean Marie
AU - Ropars, Virginie
AU - David, Gabriel
AU - Arteni, Ana Andreea
AU - Wyman, Claire
AU - Knipscheer, Puck
AU - Kanaar, Roland
AU - Zelensky, Alex N.
AU - Zinn-Justin, Sophie
N1 - Publisher Copyright:
Copyright © 2023 The Authors, some rights reserved.
PY - 2023/10
Y1 - 2023/10
N2 - In meiotic homologous recombination (HR), BRCA2 facilitates loading of the recombinases RAD51 and DMC1 at the sites of double-strand breaks (DSBs). The HSF2BP-BRME1 complex interacts with BRCA2. Its absence causes a severe reduction in recombinase loading at meiotic DSB. We previously showed that, in somatic cancer cells ectopically producing HSF2BP, DNA damage can trigger HSF2BP-dependent degradation of BRCA2, which prevents HR. Here, we report that, upon binding to BRCA2, HSF2BP forms octameric rings that are able to interlock into a large ring-shaped 24-nucleotide oligomer. Addition of BRME1 leads to dissociation of both of these ring structures and cancels the disruptive effect of HSF2BP on cancer cell resistance to DNA damage. It also prevents BRCA2 degradation during interstrand DNA crosslink repair in Xenopus egg extracts. We propose that, during meiosis, the control of HSF2BP-BRCA2 oligomerization by BRME1 ensures timely assembly of the ring complex that concentrates BRCA2 and controls its turnover, thus promoting HR.
AB - In meiotic homologous recombination (HR), BRCA2 facilitates loading of the recombinases RAD51 and DMC1 at the sites of double-strand breaks (DSBs). The HSF2BP-BRME1 complex interacts with BRCA2. Its absence causes a severe reduction in recombinase loading at meiotic DSB. We previously showed that, in somatic cancer cells ectopically producing HSF2BP, DNA damage can trigger HSF2BP-dependent degradation of BRCA2, which prevents HR. Here, we report that, upon binding to BRCA2, HSF2BP forms octameric rings that are able to interlock into a large ring-shaped 24-nucleotide oligomer. Addition of BRME1 leads to dissociation of both of these ring structures and cancels the disruptive effect of HSF2BP on cancer cell resistance to DNA damage. It also prevents BRCA2 degradation during interstrand DNA crosslink repair in Xenopus egg extracts. We propose that, during meiosis, the control of HSF2BP-BRCA2 oligomerization by BRME1 ensures timely assembly of the ring complex that concentrates BRCA2 and controls its turnover, thus promoting HR.
UR - https://www.scopus.com/pages/publications/85175274845
U2 - 10.1126/SCIADV.ADI7352
DO - 10.1126/SCIADV.ADI7352
M3 - Article
C2 - 37889963
AN - SCOPUS:85175274845
VL - 9
JO - Science advances
JF - Science advances
IS - 43
M1 - eadi7352
ER -